TherapeuticsMD (TXMD) Tops Q3 EPS by 2c

TherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low